AIDS Research and Therapy最新文献

筛选
英文 中文
Brief communication: targeted serum proteomics in postpartum South African women living with and without HIV, correlations with anthropometry and adiposity. 简要交流:南非产后感染和不感染艾滋病毒妇女的靶向血清蛋白质组学,与人体测量和肥胖的相关性。
IF 2.5 4区 医学
AIDS Research and Therapy Pub Date : 2025-08-04 DOI: 10.1186/s12981-025-00782-0
Hlengiwe P Madlala, Junyu Chen, Jennifer Jao, Landon Myer, Amy E Mendham, Carmen Pheiffer, Liam Bell, Lara R Dugas, Julia H Goedecke, Yan V Sun, Angela M Bengtson
{"title":"Brief communication: targeted serum proteomics in postpartum South African women living with and without HIV, correlations with anthropometry and adiposity.","authors":"Hlengiwe P Madlala, Junyu Chen, Jennifer Jao, Landon Myer, Amy E Mendham, Carmen Pheiffer, Liam Bell, Lara R Dugas, Julia H Goedecke, Yan V Sun, Angela M Bengtson","doi":"10.1186/s12981-025-00782-0","DOIUrl":"10.1186/s12981-025-00782-0","url":null,"abstract":"<p><p>Postpartum adiposity is associated with long-term risk of cardiovascular disease (CVD), which may be influenced by HIV infection. We investigated cross-sectional correlations between postpartum adiposity measures, and circulating proteins linked to CVD in women living with and without HIV. Irrespective of HIV status, adiposity was positively correlated with fatty acid binding protein 4, leptin and galectin 9; and negatively correlated with insulin-like growth factor binding protein 2 and V-set immunoglobulin domain containing 2. The link between adiposity and CVD-linked circulating proteins underscores the role of protein markers in understanding the cardiometabolic health of postpartum women living with and without HIV. Clinical trial number: Not applicable.</p>","PeriodicalId":7503,"journal":{"name":"AIDS Research and Therapy","volume":"22 1","pages":"76"},"PeriodicalIF":2.5,"publicationDate":"2025-08-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12320358/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144783253","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Unlocking self-testing: predictors of HIV self-testing kit use among reproductive-aged women in tanzania; a multilevel analysis of the 2022 demographic and health survey. 解锁自我检测:坦桑尼亚育龄妇女使用艾滋病毒自我检测试剂盒的预测因素2022年人口与健康调查的多层次分析。
IF 2.5 4区 医学
AIDS Research and Therapy Pub Date : 2025-08-04 DOI: 10.1186/s12981-025-00774-0
Elihuruma Eliufoo Stephano, Tegemea Patrick Mwalingo, Shazra Kazumari, Emanuel James Nkuwi, Victoria Godfrey Majengo, Mtoro J Mtoro
{"title":"Unlocking self-testing: predictors of HIV self-testing kit use among reproductive-aged women in tanzania; a multilevel analysis of the 2022 demographic and health survey.","authors":"Elihuruma Eliufoo Stephano, Tegemea Patrick Mwalingo, Shazra Kazumari, Emanuel James Nkuwi, Victoria Godfrey Majengo, Mtoro J Mtoro","doi":"10.1186/s12981-025-00774-0","DOIUrl":"10.1186/s12981-025-00774-0","url":null,"abstract":"<p><strong>Background: </strong>The introduction of HIV self-testing (HIVST) kits has revolutionized HIV prevention by offering a confidential and accessible option, particularly for vulnerable groups. Despite this, uptake varies widely due to multiple influencing factors. In Tanzania, where HIV prevalence among women remains high, the determinants of HIVST use are not well understood. This study addresses this gap by analyzing the 2022 Tanzania Demographic and Health Survey (TDHS), aiming to identify key predictors of HIVST uptake among women of reproductive age.</p><p><strong>Methods: </strong>This study conducted a cross-sectional analysis using 2022 TDHS data. Data management and analysis were performed using Stata 18. Given the survey's complex design, a multilevel mixed-effect logistic regression model was used to identify predictors of HIVST kit use, with results presented as adjusted odds ratios (AORs) and 95% confidence intervals (CIs). Statistical significance was set at p < 0.05.</p><p><strong>Results: </strong>The prevalence of HIVST kit usage among women of reproductive age in Tanzania was 3.2% (95% CI: 2.8-3.7%). Individual-level factors associated with a higher likelihood of HIVST kit use included age, 25-34 (AOR = 1.93, 95%CI: 1.43-2.60) and 35-49 (AOR = 1.60, 95%CI:1.43-2.26), secondary/higher education (AOR = 2.77, 95%CI: 1.57-4.85), belonging to the rich wealth quintile (AOR = 2.69, 95%CI: 1.52-4.77), internet use (AOR = 3.04, 95%CI: 2.04-4.52), awareness of sexually transmitted infections (STIs) (AOR = 2.03, 95%CI: 1.21-3.42), and one or higher number of sexual partners. At the community level, geographical zone was associated with increased odds of use, while living in a high poverty level community (AOR = 0.52, 95%CI: 0.30-0.89) was associated with a lower likelihood of HIVST kit use.</p><p><strong>Conclusion: </strong>This study highlights a low uptake of HIVST kits among reproductive-aged women in Tanzania, driven by both individual and community factors. Higher education and STI awareness significantly increase HIVST use, indicating the need for education and targeted health communication. Additionally, community poverty underscores the importance of economic empowerment and resource support to improve access. Addressing these factors can help tailor interventions to boost HIVST uptake and reduce HIV transmission in Tanzania.</p>","PeriodicalId":7503,"journal":{"name":"AIDS Research and Therapy","volume":"22 1","pages":"77"},"PeriodicalIF":2.5,"publicationDate":"2025-08-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12320334/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144783254","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
HIV drug resistance in children and adolescents on NNRTI-based antiretroviral therapy and subsequent virologic response to dolutegravir-based regimens in Ghana. 在加纳,儿童和青少年在接受基于nnrti的抗逆转录病毒治疗时的艾滋病毒耐药性,以及随后对基于多替格雷韦的治疗方案的病毒学反应。
IF 2.5 4区 医学
AIDS Research and Therapy Pub Date : 2025-07-26 DOI: 10.1186/s12981-025-00762-4
Adwoa K A Afrane, Vlad Novitsky, Joel Hague, Kwamena Sagoe, Yakubu Alhassan, Joycelyn Assimeng Dame, Charles Martyn-Dickens, Margaret Lartey, Bamenla Goka, Kwasi Torpey, Rami Kantor, Awewura Kwara
{"title":"HIV drug resistance in children and adolescents on NNRTI-based antiretroviral therapy and subsequent virologic response to dolutegravir-based regimens in Ghana.","authors":"Adwoa K A Afrane, Vlad Novitsky, Joel Hague, Kwamena Sagoe, Yakubu Alhassan, Joycelyn Assimeng Dame, Charles Martyn-Dickens, Margaret Lartey, Bamenla Goka, Kwasi Torpey, Rami Kantor, Awewura Kwara","doi":"10.1186/s12981-025-00762-4","DOIUrl":"10.1186/s12981-025-00762-4","url":null,"abstract":"<p><p>HIV drug resistance (HIVDR) was retrospectively characterized among 20 children and adolescents with HIV with virologic failure on non-nucleoside reverse transcriptase inhibitor (NNRTI)-based therapy, and virologic response in those switched to dolutegravir (DTG)-based therapy described. All participants had at least one NNRTI resistance mutation, most commonly K103N (N = 12) and 15 (75%) had nucleoside reverse transcriptase inhibitor (NRTI) resistance mutations, most commonly M184I/V (N = 15). Five (45%) of 11 participants who were switched to DTG-based regimens for a median of 50 months had HIV suppression. Further studies to understand the role of pre-existing HIVDR in the failure of DTG-based regimens are needed.</p>","PeriodicalId":7503,"journal":{"name":"AIDS Research and Therapy","volume":"22 1","pages":"74"},"PeriodicalIF":2.5,"publicationDate":"2025-07-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12296613/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144717248","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
"A creature inside me": perceptions and representations of HIV among adolescents living with HIV in Malawi. “我体内的生物”:马拉维感染艾滋病毒的青少年对艾滋病毒的看法和表现。
IF 2.5 4区 医学
AIDS Research and Therapy Pub Date : 2025-07-26 DOI: 10.1186/s12981-025-00770-4
Nadine Ammon, Mark Limmer, Alex Kaley
{"title":"\"A creature inside me\": perceptions and representations of HIV among adolescents living with HIV in Malawi.","authors":"Nadine Ammon, Mark Limmer, Alex Kaley","doi":"10.1186/s12981-025-00770-4","DOIUrl":"10.1186/s12981-025-00770-4","url":null,"abstract":"<p><p>Malawi is among the countries with the highest HIV prevalence worldwide. Adolescents living with HIV (ALHIV) face diverse challenges, which influence their emotional wellbeing and long-term health, in addition to impacting HIV onward transmission. HIV education, especially the use of fear-based animation, but also the figurative language used for HIV, contribute to how ALHIV perceive and respond to their HIV status. The aim of the study was to explore how ALHIV in Malawi describe, perceive, and represent HIV, with a particular focus on the role of language in shaping these perceptions and its impact on their experiences and emotional wellbeing. This study employed hermeneutic phenomenology and reflexive thematic analysis; data were collected through semi-structured in-depth interviews, focus group discussions and drawings. Participants were sampled purposively and included 16 ALHIV and five service providers. The adolescents imagined HIV as personified, harmful creature in their body with functional senses and gender identity. Those negative perceptions originated mainly from the local term used for HIV, HIV-related stigma and discrimination and HIV representations in hospital HIV books. HIV peer support groups were identified as safe environments for learning about HIV and for debating HIV-related topics, especially in view of the usually required silence and secrecy to prevent stigma. The findings enhance the understanding of participants' lived experiences and perceptions of HIV, and thus may contribute to new methods of holistic health education, tailored for adolescents to improve their emotional wellbeing and attitudes towards HIV through context-specific programmes.</p>","PeriodicalId":7503,"journal":{"name":"AIDS Research and Therapy","volume":"22 1","pages":"75"},"PeriodicalIF":2.5,"publicationDate":"2025-07-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12297767/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144717247","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Prevalence and factors associated with awareness and use of HIV self-testing kits among young women aged 15-24 in Ghana. 加纳15-24岁年轻妇女中艾滋病毒自检试剂盒的流行情况及其与认识和使用相关的因素。
IF 2.5 4区 医学
AIDS Research and Therapy Pub Date : 2025-07-26 DOI: 10.1186/s12981-025-00764-2
Martin Wiredu Agyekum, Margaret Appiah, Frank Kyei-Arthur, Grace Frempong Afrifa-Anane, Sylvester Kyei-Gyamfi, Isaac Yeboah, Marijanatu Abdulai
{"title":"Prevalence and factors associated with awareness and use of HIV self-testing kits among young women aged 15-24 in Ghana.","authors":"Martin Wiredu Agyekum, Margaret Appiah, Frank Kyei-Arthur, Grace Frempong Afrifa-Anane, Sylvester Kyei-Gyamfi, Isaac Yeboah, Marijanatu Abdulai","doi":"10.1186/s12981-025-00764-2","DOIUrl":"10.1186/s12981-025-00764-2","url":null,"abstract":"<p><strong>Introduction: </strong>HIV/AIDS remain a major health crisis globally, and it is disproportionately higher among young women. Expanding HIV testing coverage is very critical to help reduce the spread of the disease and speed up HIV epidemic control and elimination. Though there are several studies on HIV care and prevention in Ghana, few of such studies focus on HIV self-testing (HIVST). This study examined the prevalence and factors associated with the awareness and use of HIVST kits among young women aged 15-24 in Ghana.</p><p><strong>Methods: </strong>This study used the 2022 Ghana Demographic and Health Survey data conducted in 2022/2023. The sample was restricted to young women aged 15-24 who have ever had sex, yielding a sample size of 3312. The dependent variables were awareness and use of HIVST kits. Binary logistic regression models were used to examine the factors associated with awareness and use of HIVST kit.</p><p><strong>Results: </strong>Out of the 3,312 respondents, 17.8% were aware of HIVST kits, and 9.9% have ever used the HIVST kit to check their HIV status. Women with HIV testing history were more likely to be aware and use HIVST kits, while those with no formal, primary and secondary educations were less likely to be aware and use HIVST kits. Also, significant factors associated with only awareness of HIVST kits were age, ecological zones, marital status, religion, and heard of antiretrovirals (ARVs). Specifically, women aged 20-24 and those who have ever heard of ARVs were more likely to be aware of HIVST kits. Moreover, women who used condom during last sex in the past year were more likely to use the HIVST kits.</p><p><strong>Conclusion: </strong>Awareness and use of HIVST kits were generally low among young women in Ghana. Policymakers should strengthen HIV/AIDS education interventions by targeting vulnerable women (those with no, primary and secondary education, those not using condom during last sex in the past year, and those without HIV testing history) to promote the uptake of HIVST kits.</p>","PeriodicalId":7503,"journal":{"name":"AIDS Research and Therapy","volume":"22 1","pages":"72"},"PeriodicalIF":2.5,"publicationDate":"2025-07-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12297622/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144717250","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Long-term potassium monitoring and dynamics in risk of liver dysfunction among people living with HIV. HIV感染者肝功能障碍风险的长期钾监测和动态。
IF 2.5 4区 医学
AIDS Research and Therapy Pub Date : 2025-07-26 DOI: 10.1186/s12981-025-00766-0
Hong Liu, Jiamin Li, Wenjun Ma, Xia Zhang, Jianfeng Bao, Jing Gao, Yujuan Zhang, Guoxiang Zheng, Dingyan Yan, Yue Zhang, Jinsong Huang, Yinhua Ni, Fang Liu
{"title":"Long-term potassium monitoring and dynamics in risk of liver dysfunction among people living with HIV.","authors":"Hong Liu, Jiamin Li, Wenjun Ma, Xia Zhang, Jianfeng Bao, Jing Gao, Yujuan Zhang, Guoxiang Zheng, Dingyan Yan, Yue Zhang, Jinsong Huang, Yinhua Ni, Fang Liu","doi":"10.1186/s12981-025-00766-0","DOIUrl":"10.1186/s12981-025-00766-0","url":null,"abstract":"","PeriodicalId":7503,"journal":{"name":"AIDS Research and Therapy","volume":"22 1","pages":"73"},"PeriodicalIF":2.5,"publicationDate":"2025-07-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12297841/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144717249","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Characterizing treatment interruptions in the OPERA cohort and virologic outcomes after resumption with bictegravir/emtricitabine/tenofovir alafenamide. 描述OPERA队列中治疗中断的特征以及恢复使用比替替韦/恩曲他滨/替诺福韦阿拉胺后的病毒学结果。
IF 2.1 4区 医学
AIDS Research and Therapy Pub Date : 2025-07-21 DOI: 10.1186/s12981-025-00769-x
Karam Mounzer, Michael D Osterman, Laurence Brunet, Ricky K Hsu, Gerald Pierone, Jennifer S Fusco, Neia Prata Menezes, Joshua Gruber, Travis Lim, Megan Dunbar, Gregory P Fusco
{"title":"Characterizing treatment interruptions in the OPERA cohort and virologic outcomes after resumption with bictegravir/emtricitabine/tenofovir alafenamide.","authors":"Karam Mounzer, Michael D Osterman, Laurence Brunet, Ricky K Hsu, Gerald Pierone, Jennifer S Fusco, Neia Prata Menezes, Joshua Gruber, Travis Lim, Megan Dunbar, Gregory P Fusco","doi":"10.1186/s12981-025-00769-x","DOIUrl":"10.1186/s12981-025-00769-x","url":null,"abstract":"<p><strong>Background: </strong>Despite advancements in antiretroviral therapy (ART) for people with HIV, barriers to adherence remain, potentially leading to long-term gaps in adherence known as treatment interruptions. These treatment interruptions are associated with viral rebound and can impact the effectiveness of the subsequent regimen and the long-term health of the individual. We aimed to characterize unplanned ART treatment interruptions in the OPERA<sup>®</sup> cohort and investigate virologic outcomes among individuals who resumed treatment with bictegravir/emtricitabine/tenofovir alafenamide (B/F/TAF).</p><p><strong>Methods: </strong>We identified adults with HIV-1 who were active in care and on an oral ART regimen with ≥ 2 antiretrovirals, including ≥ 1 anchor agent, between 30JUN2021 and 31AUG2023. Individuals with ≥ 1 period of ≥ 45 days without any ART, based on supply from last prescription, were considered to have experienced a treatment interruption. Individuals who resumed treatment by 31AUG2023 were defined as having experienced a treatment interruption with resumption. Each interruption observed during the study period was described, allowing for multiple interruptions per person. Treatment interruptions, pre-interruption regimens, and post-interruption regimens were described. Among individuals who resumed treatment with B/F/TAF, virologic outcomes were investigated through 29FEB2024 using Kaplan-Meier methods. All analyses were repeated with treatment interruption definitions of ≥ 60 and ≥ 90 days.</p><p><strong>Results: </strong>Of 76,883 people for whom a treatment interruption could be observed, 8,550 (11%) experienced ≥ 1 period of ≥ 45 days without any ART. By 31AUG2023, 4,163 (49%) individuals resumed treatment (mean: 1.25 per person) and were included in the study population. The median age was 44 years, 81% were male, 52% Black, 41% White, and 18% Hispanic. Median time since HIV diagnosis was 118 months. B/F/TAF was the most common pre- and post-interruption regimen (49% and 51%, respectively). The cumulative probability of achieving virologic suppression on B/F/TAF was 68% (95% CI: 57, 78) when the viral load measurement was ≥ 200 copies/mL at resumption.</p><p><strong>Conclusions: </strong>Treatment interruptions occurred in 11% of ART users in routine clinical care during the 26-month study period. Despite treatment interruption increasing the risk for viral rebound, most individuals who resumed treatment with B/F/TAF were able to achieve virologic suppression or avoid virologic failure.</p>","PeriodicalId":7503,"journal":{"name":"AIDS Research and Therapy","volume":"22 1","pages":"71"},"PeriodicalIF":2.1,"publicationDate":"2025-07-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12281873/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144681804","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Knowledge, attitudes, and willingness of healthcare workers to offer pre-exposure prophylaxis in Africa: a systematic review and meta-analysis. 非洲卫生保健工作者提供暴露前预防的知识、态度和意愿:一项系统回顾和荟萃分析
IF 2.5 4区 医学
AIDS Research and Therapy Pub Date : 2025-07-18 DOI: 10.1186/s12981-025-00768-y
Victor Oluwafemi Femi-Lawal, Dimeji Abdulsobur Olawuyi, Gabriel Ilerioluwa Oke, Yetunde Nofisat Kabiawu, Olaoluwaposi Ogunlana, Jonas Paul Ibekwe, Olakulehin Adebusuyi
{"title":"Knowledge, attitudes, and willingness of healthcare workers to offer pre-exposure prophylaxis in Africa: a systematic review and meta-analysis.","authors":"Victor Oluwafemi Femi-Lawal, Dimeji Abdulsobur Olawuyi, Gabriel Ilerioluwa Oke, Yetunde Nofisat Kabiawu, Olaoluwaposi Ogunlana, Jonas Paul Ibekwe, Olakulehin Adebusuyi","doi":"10.1186/s12981-025-00768-y","DOIUrl":"10.1186/s12981-025-00768-y","url":null,"abstract":"<p><strong>Background: </strong>Despite advancements in HIV prevention strategies, including pre-exposure prophylaxis (PrEP), uptake remains suboptimal in high-burden regions like Africa. Healthcare workers (HCWs) play a pivotal role in PrEP implementation. This study systematically reviews the scientific literature to evaluate the knowledge, attitudes, and willingness of healthcare workers in offering pre-exposure prophylaxis (PrEP) in Africa.</p><p><strong>Methods: </strong>This systematic review and meta-analysis followed PRISMA guidelines, synthesizing qualitative and quantitative studies from PubMed, Cochrane CENTRAL, and Google Scholar (2010-2024). We included studies that assessed HCWs' PrEP-related knowledge, attitudes, and willingness in African settings. Pooled proportions for key outcomes were calculated using random-effects models, and barriers/facilitators were thematically analyzed.</p><p><strong>Results: </strong>Of 293 screened records, 34 studies conducted in 12 countries were included. Meta-analysis revealed high PrEP awareness (85%, 95% CI: 75-91%) but poor knowledge (18%, 95% CI: 4-55%). Attitudes were moderately positive (46%, 95% CI: 25-68%), and willingness to prescribe PrEP was 58% (95% CI: 43-72%). Key barriers included stigma, inadequate training, workload, concerns about risk compensation, and health system constraints. Facilitators included provider training, experience, and integrated service delivery.</p><p><strong>Conclusion: </strong>While PrEP awareness is high among African HCWs, knowledge gaps and attitudinal barriers hinder optimal implementation. Targeted interventions-such as structured training, stigma reduction, and health system strengthening-are critical to enhancing PrEP adoption. Future research should explore context-specific strategies to improve HCW engagement in PrEP programs.</p>","PeriodicalId":7503,"journal":{"name":"AIDS Research and Therapy","volume":"22 1","pages":"68"},"PeriodicalIF":2.5,"publicationDate":"2025-07-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12273243/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144666729","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
A bibliometric mapping study of the literature on the quality of life of people living with HIV. 一项关于艾滋病毒感染者生活质量的文献计量测绘研究。
IF 2.1 4区 医学
AIDS Research and Therapy Pub Date : 2025-07-18 DOI: 10.1186/s12981-025-00772-2
Can Huang, Yanfang Sun, Meng Chen, Lin Zhang, Wei Liu
{"title":"A bibliometric mapping study of the literature on the quality of life of people living with HIV.","authors":"Can Huang, Yanfang Sun, Meng Chen, Lin Zhang, Wei Liu","doi":"10.1186/s12981-025-00772-2","DOIUrl":"10.1186/s12981-025-00772-2","url":null,"abstract":"<p><strong>Background: </strong>In recent years, owing to the implementation of highly active antiretroviral therapy (HAART), human immunodeficiency virus (HIV) has become a manageable chronic disease. Consequently, the quality of life (QOL) of people living with HIV (PLWH) has warranted increasing attention. Although a substantial number of articles on QOL among PLWH have been published, statistical analysis of the data presented in these publications remains lacking. This study aimed to identify and analyze emerging trends and collaborative networks in research on the QOL of PLWH.</p><p><strong>Methods: </strong>Research publications on the QOL of PLWH from 1992 to 2025 were collected from the Web of Science Core Collection. After screening and deduplication, the following bibliometric data were extracted from each article: title, abstract, keywords, authors, affiliations, geographic origin (countries/regions), publication year, journal name, and references. Various scientometric mapping tools-including Microsoft Office Spreadsheet, VOSviewer, and the Bibliometrix R-package-were used to analyze basic bibliometric parameters, leading contributors, high-impact keywords, and research trends.</p><p><strong>Results: </strong>A total of 6,163 publications met the inclusion criteria. Over the past 33 years, the annual number of publications has shown an overall upward trend. The United States had the highest number of publications (n = 2,432) and the highest total link strength (TLS = 1,798) in collaborative research. The University of California, San Francisco, served as the core institution, and PLOS ONE was the most prolific journal. Wu AW was identified as a core member of the industry collaboration network. By combining keyword co-occurrence and co-citation analyses, this study found that clinical concerns (e.g., antiretroviral therapy adherence, depression, anxiety) remained prominent, while stigma, healthcare access, and age-related impairments emerged as the latest hotspots with strong burst strength.</p><p><strong>Conclusions: </strong>This bibliometric analysis highlights the growing importance of QOL research in the field of PLWH, which can inform clinicians, researchers, and policymakers to prioritize areas for future investigation in order to develop comprehensive, patient-centered strategies. The findings advocate for appropriate resources for interventions that benefit HIV populations and a better understanding of the psychosocial needs of PLWH to improve their QOL.</p>","PeriodicalId":7503,"journal":{"name":"AIDS Research and Therapy","volume":"22 1","pages":"69"},"PeriodicalIF":2.1,"publicationDate":"2025-07-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12273392/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144666727","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Attitudes and eligibility of long-acting cabotegravir/rilpivirine treatment among youth living with HIV in a clinical and national cohort in Thailand: a cross-sectional study. 在泰国的一项临床和国家队列研究中,青年艾滋病毒感染者对长效卡博特韦/利匹韦林治疗的态度和资格:一项横断面研究。
IF 2.1 4区 医学
AIDS Research and Therapy Pub Date : 2025-07-18 DOI: 10.1186/s12981-025-00771-3
Punnathorn Auaboonkanok, Wipaporn Natalie Songtaweesin, Suvaporn Anugulruengkitt, Chutima Saisaengjan, Jinnaphak Seesuksai, Sirinya Teeraananchai, Thanyawee Puthanakit
{"title":"Attitudes and eligibility of long-acting cabotegravir/rilpivirine treatment among youth living with HIV in a clinical and national cohort in Thailand: a cross-sectional study.","authors":"Punnathorn Auaboonkanok, Wipaporn Natalie Songtaweesin, Suvaporn Anugulruengkitt, Chutima Saisaengjan, Jinnaphak Seesuksai, Sirinya Teeraananchai, Thanyawee Puthanakit","doi":"10.1186/s12981-025-00771-3","DOIUrl":"10.1186/s12981-025-00771-3","url":null,"abstract":"<p><strong>Background: </strong>Long-acting cabotegravir/rilpivirine (LA-CAB/RPV) is the only available approved injectable antiretroviral therapy (ART) for youth living with HIV (YLHIV). However, it is not yet available through the Thai National AIDS Program (NAP). This study assessed Thai YLHIV attitudes toward LA-CAB/RPV and identified the proportion of medically eligible YLHIV within the NAP.</p><p><strong>Methods: </strong>Two cross-sectional studies were conducted, the first study conducted in an HIV clinic in Bangkok involving YLHIV aged 13-24 years, assessing attitudes via questionnaires. The second study analyzed medical eligibility among 14,670 youth aged 12-24 years in the NAP, defined by current HIV RNA < 50 copies/ml, no prior treatment failure (HIV RNA < 1,000 copies/ml) and no suspected archived resistance to CAB/RPV. Logistic regression was performed to identify factors associated with willingness and eligibility.</p><p><strong>Results: </strong>From April to June 2024, 100 YLHIV (median age 20 years; IQR 19.0-21.7) were enrolled, 71% had non-perinatally acquired HIV (non-PHIV). Overall, 85% expressed willingness to use LA-CAB/RPV. Non-PHIV youth showed significantly higher interest (93.0% vs. 65.5%); OR 6.9 [95% CI: 2.1-22.8], despite a shorter median treatment duration (2.7 vs. 14.3 years). LA-CAB/RPV was considered more convenient than pills by 76%, although 42% anticipated injection-site reactions. Among YLHIV in the NAP (median age 22 years; IQR 20-23), 64% were medically eligible, non-PHIV youth also had a higher eligibility proportion (70% vs. 32%) with an aOR 2.0 [95% CI: 1.7-2.4].</p><p><strong>Conclusion: </strong>The majority of Thai YLHIV showed positive attitudes towards LA-CAB/RPV, with two-thirds meeting medical eligibility criteria. Enhancing access to generic formulations of this regimen could significantly impact lifelong HIV management.</p>","PeriodicalId":7503,"journal":{"name":"AIDS Research and Therapy","volume":"22 1","pages":"70"},"PeriodicalIF":2.1,"publicationDate":"2025-07-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12273272/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144666728","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
相关产品
×
本文献相关产品
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信